Changes in Beneficial Ownership · 4

Ginkgo Bioworks Holdings, Inc.

DNANYSEEQUITYCurrent

Changes in Beneficial Ownership

Filed Jul 30, 2026Accepted Jul 30, 2026, 4:28 PM EDTFiling CIK 1830214Accession 0001628280-26-051089

wk-form4_1785443315.xml

Derivative transactions · 4 reported rows
Security	Conversion / exercise price (USD)	Transaction date	Code	Amount	A / D	Price (USD)	Exercisable	Expires	Underlying security	Underlying shares	Owned after	Ownership	Nature of ownership
Restricted Stock Units	^[F1]	2026-07-28	A · Form 4	35,736	A	^[F1]	^[F2]	^[F2]	Class A Common Stock	35,736	35,736	D
Restricted Stock Units	^[F1]	2026-07-28	A · Form 4	117,135	A	^[F1]	^[F3]	^[F3]	Class A Common Stock	117,135	117,135	D
Restricted Stock Units	^[F1]	2026-07-28	A · Form 4	39,038	A	^[F1]	^[F2]	^[F2]	Class A Common Stock	39,038	39,038	I	By Spouse
Restricted Stock Units	^[F1]	2026-07-28	A · Form 4	127,423	A	^[F1]	^[F3]	^[F3]	Class A Common Stock	127,423	127,423	I	By Spouse

Table key

F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.↩ 1 ↩ 2 ↩ 3 ↩ 4 ↩ 5 ↩ 6 ↩ 7 ↩ 8
F2: The RSUs were approved by the Compensation Committee of the Board of Directors on July 28, 2026 and shall vest as follows: 75% on October 16, 2026 and 25% on January 21, 2027.↩ 1 ↩ 2 ↩ 3 ↩ 4
F3: The RSUs were approved by the Compensation Committee of the Board of Directors on July 28, 2026 and shall vest in equal quarterly installments over the next 12 quarters, with the first vesting to occur on October 16, 2026.↩ 1 ↩ 2 ↩ 3 ↩ 4

Historical securities (5)